NASDAQ:BIOT - Nasdaq - KYG1125A1085 - Common Stock - Currency: USD
MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash Equivalents | 13.15K | 91.41K | N/A | |||
Other Current Assets | 82.11K | 208.06K | 90.00K | |||
Total Current Assets | 95.25K | 299.46K | 90.00K | |||
Non-Current Assets | ||||||
Investments And Advances | 231.29M | 230.02M | N/A | |||
Total Non-Current Assets | 231.29M | 230.02M | 0.00 | |||
TOTAL ASSETS | 231.39M | 230.32M | 90.00K | |||
LIABILITIES | ||||||
Current Liabilities | ||||||
Short Term Debt | 304.98K | 0.00 | 70.00K | |||
Accrued Expenses | 3.21M | 312.94K | N/A | |||
Other Current Liabilities | 3.37K | 870.00 | N/A | |||
Total Current Liabilities | 3.52M | 313.81K | 70.00K | |||
Non-Current Liabilities | ||||||
Long Term Debt | 0.00 | 0.00 | 0.00 | |||
Other Non-Current Liabilities | 9.70M | 27.16M | N/A | |||
Total Non-Current Liabilities | 9.70M | 27.16M | 0.00 | |||
TOTAL LIABILITIES | 13.22M | 27.47M | 70.00K | |||
SHAREHOLDERS' EQUITY | ||||||
Retained Earnings | -13.12M | -27.17M | -10.00K | |||
Additional Paid In Capital | 0.00 | 0.00 | 20.00K | |||
Common Shares | 231.29M | 230.02M | 0.00 | |||
Shares Outstanding | 28.75M | 28.75M | 25.75M | |||
Tangible Book Value per Share | 7.59 | 7.06 | 0.00 | |||
Total Shareholders' Equity | 218.17M | 202.85M | 20.00K | |||
TOTAL LIABILITIES AND EQUITY | 231.39M | 230.32M | 90.00K | |||
Statistics | ||||||
Current Ratio | 0.03 | 0.95 | 1.29 | |||
Return On Assets (ROA) | 3.47% | -2.98% | -11.11% | |||
Return On Equity (ROE) | 3.68% | -3.38% | -50.00% |
All data in USD , ROIC based on taxRate of 0.21